Indaptus Therapeutics Stock Price Prediction

INDP Stock  USD 2.44  0.02  0.83%   
As of today, The RSI of Indaptus Therapeutics' share price is at 55. This usually indicates that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Indaptus Therapeutics, making its price go up or down.

Oversold Vs Overbought


The successful prediction of Indaptus Therapeutics' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Indaptus Therapeutics, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Indaptus Therapeutics' stock price prediction:
EPS Estimate Next Quarter
EPS Estimate Current Year
EPS Estimate Next Year
Wall Street Target Price
EPS Estimate Current Quarter
Using Indaptus Therapeutics hype-based prediction, you can estimate the value of Indaptus Therapeutics from the perspective of Indaptus Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Indaptus Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Indaptus because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Indaptus Therapeutics after-hype prediction price

  USD 2.4  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Indaptus Therapeutics Basic Forecasting Models to cross-verify your projections.
To learn how to invest in Indaptus Stock, please use our How to Invest in Indaptus Therapeutics guide.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Indaptus Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
2 Analysts
Estimates (0)
LowProjected EPSHigh

Indaptus Therapeutics After-Hype Price Prediction Density Analysis

As far as predicting the price of Indaptus Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Indaptus Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Indaptus Therapeutics, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Indaptus Therapeutics Estimiated After-Hype Price Volatility

In the context of predicting Indaptus Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Indaptus Therapeutics' historical news coverage. Indaptus Therapeutics' after-hype downside and upside margins for the prediction period are 0.12 and 8.33, respectively. We have considered Indaptus Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
After-hype Price
Indaptus Therapeutics is very risky at this time. Analysis and calculation of next after-hype price of Indaptus Therapeutics is based on 3 months time horizon.

Indaptus Therapeutics Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Indaptus Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Indaptus Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Indaptus Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
7 Events / Month
3 Events / Month
In about 7 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

Indaptus Therapeutics Hype Timeline

Indaptus Therapeutics is currently traded for 2.44. The entity has historical hype elasticity of -0.04, and average elasticity to hype of competition of 0.14. Indaptus is forecasted to decline in value after the next headline, with the price expected to drop to 2.4. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -1.64%, whereas the daily expected return is currently at 0.55%. The volatility of related hype on Indaptus Therapeutics is about 2348.51%, with the expected price after the next announcement by competition of 2.58. About 31.0% of the company shares are held by company insiders. The book value of Indaptus Therapeutics was currently reported as 1.1. The company recorded a loss per share of 1.77. Indaptus Therapeutics last dividend was issued on the 30th of October 2020. The entity had 1:4 split on the 27th of July 2021. Given the investment horizon of 90 days the next forecasted press release will be in about 7 days.
Check out Indaptus Therapeutics Basic Forecasting Models to cross-verify your projections.
To learn how to invest in Indaptus Stock, please use our How to Invest in Indaptus Therapeutics guide.

Indaptus Therapeutics Related Hype Analysis

Having access to credible news sources related to Indaptus Therapeutics' direct competition is more important than ever and may enhance your ability to predict Indaptus Therapeutics' future price movements. Getting to know how Indaptus Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Indaptus Therapeutics may potentially react to the hype associated with one of its peers.

Indaptus Therapeutics Additional Predictive Modules

Most predictive techniques to examine Indaptus price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Indaptus using various technical indicators. When you analyze Indaptus charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Indaptus Therapeutics Predictive Indicators

The successful prediction of Indaptus Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Indaptus Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Indaptus Therapeutics based on analysis of Indaptus Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Indaptus Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Indaptus Therapeutics's related companies.
 2021 2022 2023 2024 (projected)
Current Ratio8.777.945.053.88
Net Debt To EBITDA5.040.640.811.15

Story Coverage note for Indaptus Therapeutics

The number of cover stories for Indaptus Therapeutics depends on current market conditions and Indaptus Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Indaptus Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Indaptus Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Indaptus Therapeutics Short Properties

Indaptus Therapeutics' future price predictability will typically decrease when Indaptus Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Indaptus Therapeutics often depends not only on the future outlook of the potential Indaptus Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Indaptus Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding8.4 M
Cash And Short Term Investments13.4 M

Additional Tools for Indaptus Stock Analysis

When running Indaptus Therapeutics' price analysis, check to measure Indaptus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Indaptus Therapeutics is operating at the current time. Most of Indaptus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Indaptus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Indaptus Therapeutics' price. Additionally, you may evaluate how the addition of Indaptus Therapeutics to your portfolios can decrease your overall portfolio volatility.